While most major economies continue to strive against rising infections and deaths caused by the novel coronavirus, Taiwan has set itself up for an economic revival due to its successful pandemic control measures. The CEO of iXensor,Carson Chen, invited by the Society for Promotion of East West Knowledge Transfer, gave a speech during the online conference “Taiwan as a role model in combating COVID-19” on March 2nd, highlighting Taiwan’s digital health capabilities.
iXensor, the pioneer of mobile health, utilizes its patented lighting and image sensing PixoTech technology to overcome the current testing limitations of lateral flow immunochromatographic assays, and lower false interpretation risk by human eyes. iXensor’s digitized PixoTest COVID-19 Antigen Testing provides accurate and objective antigen test results in as short as 5 minutes.
In addition, iXensor runs the extra mile to empower people who need to undertake COVID-19 testing and prove their SARS-CoV-2 free status with an encrypted PixoHealth Pass on a mobile phone. Traditionally, testees would only receive test reports in 1-3 days. By deploying iXensor’s digital COVID-19 rapid antigen testing and PixoHealth Pass App, the testees receive immediate test results on the mobile app at no cost. This also eliminates the need for manual record management for healthcare professionals on the front line.
Moreover, iXensor develops another mobile application, PixoHealth Pass Admin App, for organizations to sustain their business operations easily. This enterprise mobile application is designed to help organizations such as manufactures, corporations, schools, public places, and event organizers verify the authenticity of COVID-19 test results at the point of entry. With a simple, contactless QR code scan, access control is made easy for businesses of all sizes to screen and validate the health status of employees, customers, students, and event participants.
Dr. Carson Chen concluded that “In the digital-savvy era, we harness the power of digital connectivity, combining Taiwan’s strengths in ICT and biotechnology, to shape out the world’s first total solution of smart COVID-19 management. We aspire to support all nations in stopping the ongoing pandemic soon.” (Read the news in German)
iXensor, the pioneer of mobile health, turns smartphones into lab-grade mobile medical diagnostics. In 2017, iXensor introduced the PixoTest® Blood Glucose Monitoring System as the world’s first US FDA-approved smartphone camera-based blood test. Based on the PixoTech® platform, iXensor has ventured into at-home self-testing and clinical diagnostics across infectious diseases, women’s health, and cardiovascular diseases. Our vision is to make quality healthcare accessible and timely by driving the paradigm shift of point-of-care testing with the highly scalable PixoTech® platform.